Phosphodiesterase inhibitors and the cardiovascular system

Continuing Education in Anaesthesia, Critical Care and Pain

Volumn 7, Issue 6, 2007, Pages 203-207

  Feneck, Rob ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 36348979239     PISSN: 17431816     EISSN: 17431824     Source Type: Journal    
DOI: 10.1093/bjaceaccp/mkm039     Document Type: Article

References (15)

1. Lobato EB, Florete O, Jr, Bingham HL. A single dose of milrinone facilitates separation from cardiopulmonary bypass in patients with pre-existing left ventricular dysfunction. Br J Anaesth 1998; 81: 782-4
2. Packer M, Carver JR, Rodeheffer RJ, Ivanhoe RJ, DiBianco R, Zeldis SM, Hendrix GH, Bommer WJ, Elkayam U, Kukin ML et al. Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group. N Engl J Med 1991; 325: 1468-75
3. Lalukota K, Cleland JG, Ingle L, Clark AL, Coletta AP. Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD. Eur J Heart Fail 2004; 6: 953-5
4. Cleland JG, Coletta AP, Lammiman M, Witte KK, Loh H, Nasir M, Clark AL. Clinical trials update from the European Society of Cardiology meeting 2005: CARE-HF extension study, ESSENTIAL, CIBIS-III, S-ICD, ISSUE-2, STRIDE-2, SOFA, IMAGINE, PREAMI, SIRIUS-II and ACTIVE. Eur J Heart Fail 2005; 7: 1070-5
5. Feneck RO. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 1992; 6: 563-7
6. Feneck RO. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anesth 1992; 6: 554-62
7. Boldt J, Hammermann H, Hempelmann G. What is the place of the phosphodiesterase inhibitors? Eur J Anaesthesiol Suppl 1993; 8 33-7
8. Gold JA, Cullinane S, Chen J, Oz MC, Oliver JA, Landry DW Vasopressin as an alternative to norepinephrine in the treatment of milrinone-incluced hypotension. Crit Care Med 2000; 28: 249-52
9. Feneck RO, Sherry KM, Withington PS, Oduro-Dominah A. European Milrinone Multicenter Trial Group Comparison of the hemodynamic effects of milrinone with dobutamine in patients after cardiac surgery. J Cardiothorac Vasc Anesth 2001; 15: 306-15
10. Royster RL, Butterworth JF 4th, Prielipp RC, Zaloga GP, Lawless SG, Spray BJ, Kon ND, Wallenhaupt SL, Cordell AR. Combined inotropic effects of amrinone and epinephrine after cardiopulmonary bypass in humans. Anesth Analg 1993; 77: 662-72
11. Lobato EB, Beaver T, Muehlschlegel J, Kirby DS, Klodell C, Sidi A. Treatment with phosphodiesterase inhibitors type III and V: Milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension. Br J Anaesth 2006; 96: 317-22
12. Deb B, Bradford K, Pearl RG. Additive effects of inhaled nitric oxide and intravenous milrinone in experimental pulmonary hypertension. Crit Care Med 2000; 28: 795-9
13. Monrad ES, Baim DS, Smith HS, Lanoue A, Brauwald E, Grossman W. Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985; 71 972-9
14. Mollhoff T, Schmidt C, Van Aken H, Berendes E, Buerkle H, Marmann P, Reinbold T, Prenger-Berninghoff R, Tjan TD, Scheld HH, Deng MC. Myocardial ischaemia in patients with impaired left ventricular function undergoing coronary artery bypass grafting-milrinone versus nifedipin. Eur J Anaesthesiol 2002; 19: 796-802
15. Schwarte LA, Picker O, Bornstein SR, Fournell A, Scheeren TW. Levosimendan is superior to milrinone and dobutamine in selectively increasing microvascular gastric mucosal oxygenation in dogs. Crit Care Med 2005; 33: 135-42